Back to Search
Start Over
Serum free light chains and multiple myeloma: Is it time to extend their application?
- Source :
- Clinical Case Reports, Vol 8, Iss 4, Pp 617-624 (2020), Clinical Case Reports
- Publication Year :
- 2020
-
Abstract
- In nonsecretory, oligo‐secretory, and light chain multiple myeloma patients, serial sFLC evaluation could precede biochemical and clinical disease progression, even in extramedullary relapse, thus initiating early treatment with novel anti‐MM agents.
- Subjects :
- Oncology
medicine.medical_specialty
disease progression
extramedullary relapse
multiple myeloma
serological markers
serum free light chains
lcsh:Medicine
Case Report
Case Reports
030204 cardiovascular system & hematology
Immunoglobulin light chain
03 medical and health sciences
0302 clinical medicine
Serum free
Internal medicine
Medicine
Multiple myeloma
lcsh:R5-920
business.industry
lcsh:R
Disease progression
General Medicine
medicine.disease
Clinical disease
030220 oncology & carcinogenesis
lcsh:Medicine (General)
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Clinical Case Reports, Vol 8, Iss 4, Pp 617-624 (2020), Clinical Case Reports
- Accession number :
- edsair.doi.dedup.....d1fd413fbec4ed603d4a46f81fa86214